High Tech Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	143,442	148,864	99,208	77,268	97,116	130,788
Market Cap Growth	-8.48%	50.05%	28.39%	-20.44%	-25.75%	63.27%
Enterprise Value	130,626	153,628	111,271	89,346	110,402	138,335
Last Close Price	13490.00	13825.00	9147.57	7075.37	8836.82	11857.25
PE Ratio	12.02	10.86	12.28	13.16	-	-
PS Ratio	1.90	1.92	1.29	0.75	1.33	1.76
PB Ratio	1.13	1.24	0.93	0.77	1.03	1.38
P/TBV Ratio	1.13	1.24	0.93	0.77	1.03	1.38
P/FCF Ratio	7.82	11.85	-	-	16.00	-
P/OCF Ratio	6.98	10.13	34.11	-	14.02	-
EV/Sales Ratio	1.73	1.98	1.45	0.87	1.51	1.86
EV/EBITDA Ratio	7.32	7.41	7.38	8.53	21.49	64.99
EV/EBIT Ratio	10.46	9.88	11.03	18.13	-	-
EV/FCF Ratio	7.13	12.23	-	-	18.19	-
Debt / Equity Ratio	0	0.07	0.15	0.16	0.17	0.11
Debt / EBITDA Ratio	0.00	0.39	1.09	1.57	3.11	4.92
Debt / FCF Ratio	0.00	0.64	-	-	2.63	-
Asset Turnover	0.54	0.56	0.57	0.81	0.58	0.57
Inventory Turnover	1.70	1.92	3.18	5.88	3.86	5.13
Quick Ratio	2.44	1.48	1.31	1.15	0.97	0.77
Current Ratio	5.56	3.39	2.48	1.64	1.78	1.50
Return on Equity (ROE)	9.85%	12.09%	7.81%	6.06%	-1.30%	-3.25%
Return on Assets (ROA)	5.59%	7.07%	4.72%	2.41%	-0.21%	-1.60%
Return on Invested Capital (ROIC)	8.86%	10.48%	7.29%	4.79%	-0.41%	-3.26%
Return on Capital Employed (ROCE)	9.80%	12.80%	9.00%	4.90%	-0.40%	-3.30%
Earnings Yield	8.35%	9.21%	8.14%	7.60%	-1.26%	-2.41%
FCF Yield	12.78%	8.44%	-2.20%	-5.64%	6.25%	-6.60%
Payout Ratio	8.88%	5.17%	6.14%	6.04%	-	-
Buyback Yield / Dilution	-50.55%	-49.99%	33.33%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.